I could see this at $18 - $36+ in time. 1.6 bil
Post# of 72435
![](/assets/46931549/no_avatar_available_thumb.jpg)
1.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types
https://finance.yahoo.com/news/lilly-announce...00916.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)